Home / News

Assessing unintended consequences in AI-based neurosurgical training

Machine learning tutors affect learners in unforeseen ways, both positive and negative

Virtual reality simulators can help learners improve their technical skills faster and with no risk to patients. In the field of neurosurgery, they allow medical students to practice complex operations before using a scalpel on a real patient. When combined with artificial intelligence, these tutoring systems can offer tailored feedback like a human instructor, identifying areas where the students need to improve and making suggestions on how to achieve expert performance.

Classified as: Neuro, rolando del maestro, neurosurgery, Artificial intelligence
Category:
Published on: 19 Sep 2023

New insights into what makes multiple sclerosis worse and how to make it better

Scientists identify the first genetic marker for MS severity, opening the door to treatments for long-term disability

A study of more than 22,000 people with multiple sclerosis has discovered the first genetic variant associated with faster disease progression, which can rob patients of their mobility and independence over time.

Classified as: Neuro, Montreal Neurological Institute, MS, Multiple Sclerosis
Category:
Published on: 28 Jun 2023

New digital consent platform streamlines consent process

Partnership with Novartis Pharmaceuticals Canada Inc. has created a faster, easier way for patients to contribute to research

 

Patients can now digitally consent to be included in The Neuro’s Open Biobank (Clinical Biospecimen Imaging and Genetic Repository) and patient registry, providing a more efficient and easier way to help patients accelerate neurological disorder research and participate in clinical trials. The new platform is financially supported by Novartis Pharmaceuticals Canada Inc.

Classified as: Neuro, MNI, Open Biobank, open science, Jason Karamchandani
Category:
Published on: 16 Jun 2023

$6M grant for new Open Science patient registry

Goal is to accelerate research and let patients know how their data is helping find treatments

A $6M grant from Brain Canada will fund the creation of a new Open Science patient registry, to share data with researchers around the world and let patients see how their data is used to develop new treatments for neurological disorders.

Classified as: Neuro, Open Biobank, Brain Canada, Guy Rouleau, Jason Karamchandani, open science
Category:
Published on: 28 Apr 2023

Alpha Tau and the JGH Announce Alpha DaRT Treatment of First Patient in its Advanced Pancreatic Cancer Clinical Trial

Alpha Tau Medical Ltd. the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that its first patient with advanced inoperable pancreatic cancer has been treated in a feasibility and safety study of Alpha DaRT at the Jewish General Hospital (JGH) in Montreal, Canada, which is an affiliated teaching hospital of McGill University, Faculty of Medicine.

Category:
Published on: 4 Apr 2023

McGill researchers’ studies offer promise for lung and brain cancer treatment

Two seminal studies from McGill University, investigating immune landscapes of lung and brain tumours, were published today in Nature. This work was led by Logan Walsh, Daniela Quail and Peter Siegel, researchers at the Rosalind and Morris Goodman Cancer Institute and Philippe Joubert from Université Laval. The studies used innovative highly multiplexed imaging to create sophisticated immune atlases of lung and brain tumours and demonstrate how big data and artificial intelligence are the future of cancer research and clinical care.

Classified as: Goodman Cancer Research Institute, lung cancer, brain tumours, Artificial intelligence
Category:
Published on: 2 Feb 2023

Study finds obesity-related neurodegeneration mimics Alzheimer’s disease

Thinning in the right temporo-parietal cortex and left prefrontal cortex were similar in both groups

A new study led by scientists at The Neuro (Montreal Neurological Institute-Hospital) of McGill University finds a correlation between neurodegeneration in obese people and Alzheimer’s disease (AD) patients.

Classified as: Alzheimer's disease, neuroimaging, obesity, Neuro
Category:
Published on: 31 Jan 2023

Neuro director to co-chair new national clinical trial initiative

Consortium brings together hundreds of researchers from 28 networks, 11 trial units across the country

Today the Canadian Institutes of Health Research (CIHR) announced funding for a new clinical trial consortium co-chaired by Dr. Guy Rouleau, Director of The Neuro (Montreal Neurological Hospital-Institute).  

Classified as: Guy Rouleau, Accelerating Clinical Trials, Neuro, Montreal Neurological Institute
Category:
Published on: 19 Jan 2023

Frequent genetic cause of late-onset ataxia uncovered by a Quebec-led international collaboration

Discovery will improve diagnosis and open treatment possibilities for thousands of people with this debilitating neurodegenerative condition worldwide

A new study published on Dec. 14, 2022 in the New England Journal of Medicine reports the identification of a previously unknown genetic cause of a late-onset cerebellar ataxia, a discovery that will improve diagnosis and open new treatment avenues for this progressive condition.

Classified as: Neuro, Bernard Brais, genetics, ataxia
Category:
Published on: 15 Dec 2022

A one-stop-shop for brain imaging

Software tool brings together multiple brain maps in one place

The brain is a complex organ, and no one imaging mode can catch everything that’s going on inside it. Over the years, multiple “brain maps” have emerged, each focusing on different brain processes, from metabolism to cognitive function. While these maps are important, using them in isolation limits the discoveries researchers can make from them.

Classified as: Neuro, bratislav misic, McConnell Brain Imaging Centre, brain imaging
Category:
Published on: 6 Oct 2022

Quebec study on long COVID seeking participants

Purpose is to understand post-COVID symptom evolution and impact on patients’ lives

As of Sept. 20, 2022, there have been more than 1.1 million cases of COVID-19 in Quebec. It is estimated that 10 to 30 per cent of cases will have lingering symptoms after the acute illness. This means that as many as 330,000 Quebecers may experience what’s become known as long COVID, or post-COVID-19 syndrome.

Classified as: Lesley Fellows, covid-19, Nancy Mayo, Neurology, Neuro
Category:
Published on: 20 Sep 2022

Two Neuro faculty inducted into The Royal Society of Canada

Society recognizes distinguished Canadians who have made remarkable contributions to their academic fields and public life

Two faculty members at The Neuro (Montreal Neurological Institute-Hospital) have been inducted into The Royal Society of Canada (RSC), recognizing their contributions to our understanding of neuroscience and the human brain.

Classified as: Nathan Spreng, Heidi McBride, royal society of canada, Neuro
Category:
Published on: 6 Sep 2022

Changing how we value research

The Neuro joins two other McGill-affiliated organizations in signing The Declaration on Research Assessment

The Neuro (Montreal Neurological Institute-Hospital) has joined the Douglas Research Centre (DRC) and the Canadian Open Neuroscience Platform (CONP) in signing the San Francisco Declaration on Research Assessment (DORA), an agreement that seeks to change how scholarly research contributions are valued in hiring, promotion, and funding decisions.

Classified as: Declaration on Research Assessment, Neuro, Canadian Open Neuroscience Platform, open science, DORA
Category:
Published on: 10 Aug 2022

Boris Bernhardt wins CAN's 2022 New Investigator Award

Together with Dr. Birgit Frauscher, Bernhardt co-directs The Neuro’s new Centre of Excellence in Epilepsy

Since joining The Neuro in 2016, Boris Bernhardt, PhD, Assistant Professor of Neurology and Neurosurgery, has published pioneering research on the organization and development of the healthy brain. His achievements have been recognized this week by the Canadian Association for Neuroscience, who have awarded him the 2022 New Investigator Award.

Classified as: Boris Bernhardt, epilepsy, autism, Neuro
Category:
Published on: 12 Apr 2022

Largest ever psychedelics study maps changes of conscious awareness to neurotransmitter systems

Applying machine learning to a database of testimonials uncovers how drug-induced changes in subjective awareness are mechanistically rooted in the human brain

Psychedelics are now a rapidly growing area of neuroscience and clinical research, one that may produce much-needed new therapies for disorders such as depression and schizophrenia. Yet there is still a lot to know about how these drug agents alter states of consciousness.

Classified as: Danilo Bzdok, psychedelics, mental health, machine learning, Neuro
Category:
Published on: 16 Mar 2022

Pages

Back to top